Clinical Trial Update: A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or Overweight [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to evaluate weight-management effects of Bimagrumab and Tirzepatide, alone or in combination, in adults with obesity or overweight; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Bimagrumab (bimagrumab)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING